SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron is surging toward new all-time highs as investors capitalize on massive AI-driven demand for HBM4 memory chips, bolstered by a fresh Taiwan facility expansion and multiple analyst price target hikes. The community remains heavily focused on the upcoming earnings report, with widespread debate over whether the stock is primed for a post-earnings breakout to record levels or if the current rally has become too crowded.

New Era Energy & Digital, Inc. is an exploration and production company, which engages in selling oil and natural gas products. The company was founded on February 6, 2023 and is headquartered in Midland, TX.

New Era Energy & Digital Inc.

New Era Energy & Digital Inc. is trending as investors digest news of a new CFO appointment and ongoing management updates, while the community remains divided between bullish sentiment regarding the company's long-term potential in the data center power sector and skepticism over delayed tenant announcements and execution timelines. Investors are actively debating the significance of the new executive hire, potential hyperscaler partnerships, and the speculative nature of the firm's progress in the Permian Basin.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending due to significant regulatory milestones, including the approval of a Nuclear Safety Design Agreement for its Aurora powerhouse and a new materials license for its Atomic Alchemy subsidiary. While the stock continues to face volatility amid its pre-revenue status and recent insider selling, the community is actively debating the long-term potential of its small modular reactor technology in meeting the massive energy demands of AI data centers.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is trending following a volatile NASDAQ IPO that has seen massive intraday gains, driven by intense investor interest in its AI-driven drone autonomy software and its combat-tested history in Ukraine. The community is heavily focused on the company's low float and the potential for a continued, multi-day short squeeze, with many debating whether the stock represents a long-term defense-tech play or a speculative, high-volatility momentum trade.

lululemon athletica, Inc. engages in the business of designing, distributing, and retailing technical athletic apparel, footwear, and accessories. It operates through the following segments: Company-Operated Stores, Direct to Consumer, and Other. The company was founded by Dennis James Wilson in 1998 and is headquartered in Vancouver, Canada.

Lululemon Athletica inc.

Lululemon Athletica Inc

Lululemon is under intense market scrutiny as investors grapple with cooling North American sales, leadership uncertainty surrounding a prolonged CEO search, and public criticism from founder Chip Wilson. Community discussions remain highly divided, with bulls pointing to the company's strong international growth and stock buyback programs while bears highlight rising competitive pressure from brands like Alo and Vuori.

Tectonic is a decentralised non-custodial algorithmic-based money market protocol that allows users to participate as liquidity suppliers or borrowers. Suppliers provide liquidity to the market to earn a passive income, while borrowers are able to borrow liquidity in an over-collateralized fashion.

Tectonic

Tectonic is seeing renewed community interest and positive price momentum, with holders closely monitoring the broader rally across the Cronos ecosystem and holding out hope that the asset can shed several zeros as long-term vaults begin to unlock. While some investors remain skeptical after years of consolidation, many are actively accumulating tokens, citing the potential for parabolic gains if the project gains wider exchange listings or initiates a token burn.

Bob’s Discount Furniture, Inc. is a holding company, which engages in the retail of home furnishings. The firm's products include reclining sofa, table lamp, storage ottoman, top coffee and end table set, rug, storage television stand, and swivel chair. Its store locations include New England, New York, Mid Atlantic, Midwest, and West. The company was founded by Robert Kaufman in 1991 and is headquartered in Manchester, CT.

Bob`s Discount Furniture Inc.

Bob's Discount Furniture is trending as investors debate its valuation and growth potential following recent earnings results and its transition into the public markets. Community discussion is sharply divided between those optimistic about the company's discount business model and omnichannel strategy and skeptics raising concerns over insider selling, tariff risks, and competitive pressure in the furniture sector.

DocuSign, Inc. engages in the provision of cloud-based electronic signature solutions, which helps companies and individuals securely collect information, automate data workflows, and sign anything. The firm automates manual and paper-based processes allowing users to manage all aspects of documented business transactions including identity management, authentication, digital signature, forms and data collection, collaboration, workflow automation, and storage. Its products include eSignature, CLM, Gen for Salesforce, Document Generation, Standards-Based Signatures, Notary and Web Forms. The company was founded by Thomas H. Gonser and Court Lorenzini in 2003 and is headquartered in San Francisco, CA.

DocuSign Inc

DocuSign is capturing investor attention as it pivots toward its AI-native Intelligent Agreement Management (IAM) platform, a move intended to deepen its moat against e-signature competitors. While the community remains divided over whether the company's valuation and transition merit its current price, active discussions are focused on the stock's potential for a short squeeze, its role as a strategic buyout candidate, and the ongoing debate regarding whether AI integration will ultimately commoditize or elevate its core business.

Williams-Sonoma, Inc. engages in the retailing of home products. It operates through the following segments: Pottery Barn, West Elm, Williams Sonoma, Pottery Barn Kids and Teen and Other. The Other segment includes net revenues from international franchise operations, Rejuvenation and Mark and Graham. The company was founded by Charles E. Williams on September 15, 1956 and is headquartered in San Francisco, CA.

Williams-Sonoma, Inc.

Williams-Sonoma is trending as traders closely scrutinize its recent performance and valuation, with discussions focusing on the impact of potential furniture tariffs on its import-heavy supply chain and whether the stock's recent price action signals a sustained trend or a vulnerable setup. Investors are actively debating the company's long-term resilience against housing market pressures and high-end discretionary spending shifts.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is surging as investors react to a positive update showing a significant reduction in breast cancer recurrence rates within the open-label arm of its ongoing Phase III clinical trial. The community is actively discussing the stock's potential for a major valuation re-rating, highlighting the upcoming release of abstract titles for the AACR conference and the strategic backing of a high-profile steering committee as key catalysts for sustained interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Prothena Announces Achievement of $50 Million Clinical Milestone Payment from Novo Nordisk Related to Ongoing Phase 3 Clinical Trial for Coramitug (Formerly PRX004) in ATTR Amyloidosis with Cardiomyopathy

Prothena Corporation plc (NASDAQ:PRTA) today announced that the Company earned a $50 million milestone payment from Novo Nordisk related to the achievement of a prespecified enrollment target in the...

Wall Street Analysts Believe Prothena (PRTA) Could Rally 118.09%: Here's is How to Trade

The consensus price target hints at an 118.1% upside potential for Prothena (PRTA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Prothena (NASDAQ:PRTA) Shares Up 8.7% - Still a Buy?

Prothena (NASDAQ:PRTA) Trading 8.7% Higher - Should You Buy...

Prothena Corporation plc (NASDAQ:PRTA) Given Average Recommendation of "Hold" by Analysts

Prothena Corporation plc (NASDAQ:PRTA - Get Free Report) has earned a consensus rating of "Hold" from the eleven brokerages that are currently covering the firm, MarketBeat reports. Two equities...

Prothena To Buy Back Up To $100 Mln Of Shares

(RTTNews) - Prothena Corporation plc (PRTA) announced that its board has authorized a share repurchase plan allowing the company to buy back up to $100 million of its outstanding ordinary shares...

Prothena Announces up to $100 Million Share Repurchase Plan

Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, today announced...

FY2026 EPS Estimates for Prothena Boosted by HC Wainwright

Prothena Corporation plc (NASDAQ:PRTA - Free Report) - Investment analysts at HC Wainwright upped their FY2026 earnings per share estimates for shares of Prothena in a report released on Friday...

Prothena (NASDAQ:PRTA) Price Target Raised to $12.00

Royal Bank Of Canada lifted their target price on shares of Prothena from $11.00 to $12.00 and gave the stock a "sector perform" rating in a report on Friday...

Prothena Q4 Earnings Meet Estimates, Pipeline Progress in Focus

PRTA posts a narrower year-over-year Q4 loss. Revenues miss estimates, as it outlines 2026 cash burn guidance and eyes key milestones from partners.

Prothena Q4 Earnings Call Highlights

Prothena (NASDAQ:PRTA) used its fourth-quarter and full-year 2025 results call to highlight partner-driven clinical momentum, updates from its wholly owned preclinical portfolio, and a sharper cash...

Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firm’s clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.

PRTA
Prothena Corporation plc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest PRTA News

PRTAProthena Corporation plc